Cognitive decline
Cognitive decline refers to a reduction in cognitive abilities such as memory, attention, executive function, processing speed, and learning.
Cognitive decline refers to a reduction in cognitive abilities such as memory, attention, executive function, processing speed, and learning. It is a clinical and research term used across the spectrum from normal aging-related change to mild cognitive impairment and dementia. In biomedical research, cognitive decline is often studied as a shared outcome of neurodegenerative disease, vascular injury, metabolic dysfunction, inflammation, sleep disorders, environmental exposures, and psychosocial factors.
The recent literature highlights cognitive decline as a multifactorial process rather than a single disease entity. Studies in aging cohorts and disease-specific populations have linked it to Alzheimer disease biomarkers such as plasma p-tau217, Microtubule-associated protein tau (MAPT)-related Markers, amyloidopathy, insulin resistance, neuroinflammation, oxidative stress, white matter damage, loneliness, and vascular pathology. It is also a major public health concern because it affects independence, medication adherence, caregiver burden, and healthcare utilization in older adults and in people living with dementia.
Where the papers sit
9 papers from the last 6 months study cognitive decline directly · updated from PubMed 9 Oct 2026
Study type 1 clinical trial · 3 observational · 3 human data · 1 preclinical · 1 unclassified
Themes one subject
Those 9 are all about one subject.
-
Cognitive Aging and Dementia
Risk, resilience, and care are being studied together across the dementia trajectory. Associations span refractive correction, bereavement, insulin sensitivity, metabolic dysfunction, omics signatures, and hippocampal degeneration. Other work focuses on caregiver support, home-care adaptation, and aspiration pneumonia as a marker of high healthcare use. The shared aim is earlier risk recognition and more responsive support, but the evidence remains observational or early-stage.
Papers
The 9 papers from the last 6 months that study cognitive decline directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Cognitive Aging and Dementia (9)
- Evaluating the effect of spectacle correction for refractive errors and presbyopia on cognitive function in rural older adults in China: protocol for a randomised, parallel-group, superiority trial. BMJ open · 7 Oct 2026 PMID 42843862
- Loss of a spouse and risk of cognitive decline: insights from six prospective cohort studies. Epidemiology and psychiatric sciences · 30 Sept 2026 PMID 42813925
- AMPK activation by Aldometanib from Bigujing improves metabolic and cognitive dysfunction in aging mice. Metabolic brain disease · 12 Sept 2026 PMID 42730893
- Associations of Insulin Sensitivity with Risk of All-Cause and Cause-Specific Dementia: A Prospective Cohort Study. Molecular neurobiology · 18 Jul 2026 PMID 42470526
- Omics signature of new-onset mild cognitive impairment and dementia in a population-based study. Scientific reports · 16 Jun 2026 PMID 42303781
- Aging in Place - A mixed methods study protocol of how care providers in Sweden organise and adapt granted home care services to the preferences and needs of people living with dementia. PloS one · 16 Jun 2026 PMID 42302009
- Stage-specific hippocampal network degeneration links amyloid-cognition relationships: Right subiculum as structural substrate for memory maintenance and biomarker in amyloid-positive mild cognitive impairment. NeuroImage · 3 Jun 2026 PMID 42235661
- Multicomponent School of Caring Program to Support Caregivers of Patients With Dementia: A Quasi-Experimental Effectiveness Study in Primary Care. Annals of family medicine · 26 May 2026 PMID 42191378
- Aspiration Pneumonia as a Marker of a High Healthcare Utilisation Trajectory in Older Adults With Dementia: A Retrospective Cohort Study. Australasian journal on ageing · 22 May 2026 PMID 42168828
By study type
Clinical trials (1)
- Evaluating the effect of spectacle correction for refractive errors and presbyopia on cognitive function in rural older adults in China: protocol for a randomised, parallel-group, superiority trial. BMJ open · 7 Oct 2026 PMID 42843862
Observational studies and case reports (3)
- Loss of a spouse and risk of cognitive decline: insights from six prospective cohort studies. Epidemiology and psychiatric sciences · 30 Sept 2026 PMID 42813925
- Associations of Insulin Sensitivity with Risk of All-Cause and Cause-Specific Dementia: A Prospective Cohort Study. Molecular neurobiology · 18 Jul 2026 PMID 42470526
- Aspiration Pneumonia as a Marker of a High Healthcare Utilisation Trajectory in Older Adults With Dementia: A Retrospective Cohort Study. Australasian journal on ageing · 22 May 2026 PMID 42168828
Human data, design not indexed (3)
- Aging in Place - A mixed methods study protocol of how care providers in Sweden organise and adapt granted home care services to the preferences and needs of people living with dementia. PloS one · 16 Jun 2026 PMID 42302009
- Stage-specific hippocampal network degeneration links amyloid-cognition relationships: Right subiculum as structural substrate for memory maintenance and biomarker in amyloid-positive mild cognitive impairment. NeuroImage · 3 Jun 2026 PMID 42235661
- Multicomponent School of Caring Program to Support Caregivers of Patients With Dementia: A Quasi-Experimental Effectiveness Study in Primary Care. Annals of family medicine · 26 May 2026 PMID 42191378
Preclinical: animal, cell and lab studies (1)
- AMPK activation by Aldometanib from Bigujing improves metabolic and cognitive dysfunction in aging mice. Metabolic brain disease · 12 Sept 2026 PMID 42730893
Unclassified: not yet indexed with MeSH (1)
- Omics signature of new-onset mild cognitive impairment and dementia in a population-based study. Scientific reports · 16 Jun 2026 PMID 42303781
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-06-24. Last written: 2026-07-29 by GPT. Drafted by language models from published abstracts; not medical advice.